Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants.

Authors:
Haycroft ER; Davis SK; Ramanathan P; Lopez E; Purcell RA and 13 more

Journal:
Med Microbiol Immunol

Publication Year: 2023

DOI:
10.1007/s00430-023-00773-w

PMCID:
PMC10372118

PMID:
37477828

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Med Microbiol Immunol

Abbreviation: Med Microbiol Immunol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Inflammation, the kynurenines, and mucosal injury during human experimental enterotoxigenic Escheri…
Rim S; Vedøy OB; Brønstad I and 4 more (2024) - Transparency Score: 5/6
Automated antigen assays display a high heterogeneity for the detection of SARS-CoV-2 variants of c…
Osterman A; Krenn F; Iglhaut M and 19 more (2023) - Transparency Score: 3/6
Phenotypic and genotypic identification of carbapenem resistance in Bacteroides fragilis clinical s…
Kierzkowska M; Majewska A; Karłowicz K and 1 more (2023) - Transparency Score: 3/6
Ten rapid antigen tests for SARS-CoV-2 widely differ in their ability to detect Omicron-BA.4 and -B…
Krenn F; Dächert C; Badell I and 17 more (2023) - Transparency Score: 3/6
The quantity and quality of anti-SARS-CoV-2 antibodies show contrariwise association with COVID-19 …
Hajilooi M; Keramat F; Moazenian A and 2 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestDIG and NAG declare that they have provisional patents submitted describing a SARS-CoV-2 RBD vaccine. The other authors have declared that no conflict of interest exists. Conflict of interest DIG and NAG declare that they have provisional patents submitted describing a SARS-CoV-2 RBD vaccine. The other authors have declared that no conflict of interest exists."

Evidence found in paper:

"Funding Open Access funding enabled and organized by CAUL and its Member Institutions."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025